Cytotoxic Compounds in the Treatment of Castration-Resistant Prostate Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 9, Iss. 10, 2009-12 ,pp. : 1040-1045

Bentham Science Publishers

Access to resources Recommend Favorite

Quality of Life Associated with Treatment of Castration-Resistant Prostate Cancer: A Review of the Literature

By Moul Judd W.   Dawson Nancy  

Cancer Investigation, Vol. 30, Iss. 1, 2012-01 ,pp. : 1-12

Informa Healthcare

Access to resources Recommend Favorite

Effect of abiraterone acetate on fatigue in patients with metastatic castration-resistant prostate cancer after docetaxel chemotherapy

By Sternberg C. N.   Molina A.   North S.   Mainwaring P.   Fizazi K.   Hao Y.   Rothman M.   Gagnon D. D.   Kheoh T.   Haqq C. M.   Cleeland C.   de Bono J. S.   Scher H. I.  

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 1017-1025

Oxford University Press

Access to resources Recommend Favorite

Carboplatin-etoposide combination chemotherapy in metastatic castration-resistant prostate cancer: A retrospective study

By                      

Molecular and Clinical Oncology, Vol. 3, Iss. 6, 2015-01 ,pp. : 1208-1212

Science Publishers

Access to resources Recommend Favorite

Health-related quality of life in prostate cancer

By Torvinen Saku   Färkkilä Niilo   Sintonen Harri   Saarto Tiina   Roine Risto P.   Taari Kimmo  

Acta Oncologica, Vol. 52, Iss. 6, 2013-08 ,pp. : 1094-1101

Informa Healthcare

Access to resources Recommend Favorite